购物车
- 全部删除
- 您的购物车当前为空
A8SGLP-1 TFA为口服活性GLP-1类似物,8位丙氨酸被丝氨酸替代。在不干扰功能的前提下,可降低db/db小鼠血糖水平。
A8SGLP-1 TFA为口服活性GLP-1类似物,8位丙氨酸被丝氨酸替代。在不干扰功能的前提下,可降低db/db小鼠血糖水平。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | 待询 | 期货 | |
50 mg | 待询 | 期货 |
产品描述 | A8SGLP-1 TFA, an orally active GLP-1 analogue, features a serine substitution for alanine at position 8. This compound effectively lowers blood glucose in db/db mice, maintaining its function [1]. |
分子量 | 3370.68 (free acid) |
分子式 | C151H229N41O47.xC2HF3O2 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容